CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 29 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,030,000 | +566.1% | 500,000 | +376.2% | 1.11% | +224.9% |
| Q2 2017 | $605,000 | +24.7% | 105,000 | -58.0% | 0.34% | +79.1% |
| Q3 2015 | $485,000 | -24.9% | 250,000 | +4.2% | 0.19% | -6.4% |
| Q2 2015 | $646,000 | -81.3% | 240,000 | -52.0% | 0.20% | -86.0% |
| Q1 2015 | $3,460,000 | +181.5% | 500,000 | +300.0% | 1.46% | +144.9% |
| Q4 2014 | $1,229,000 | +43.7% | 125,000 | 0.0% | 0.59% | +30.0% |
| Q3 2014 | $855,000 | – | 125,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |